ArticleInternational journal of general medicine2024

The Pan-Cancer Analysis Uncovers the Prognostic and Immunotherapeutic Significance of CD19 as an Immune Marker in Tumor.

Lanyi Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.